发明人马晓峰,高志强,胡光. "一种塞瑞替尼杂质9的合成方法" [P]. 中国发明专利, 专利号 CN 108567376 A, 授权公告日 2015-01-12.
Rossi M, Johansson L, Kowalski A. "Method for the Synthesis of Ceritinib Impurity 9" [P]. European Patent, EP 3495580 A1, 2021-10-12.
发明人郭海燕,韩伟,黄志刚. "A Process for Preparing High-Purity Ceritinib Impurity 9" [P]. 中国发明专利, 专利号 CN 109529239 A, 授权公告日 2015-01-16.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质9 in Pharmaceutical Formulations". Anal. Chem., 2018, 1254, (2), 3231-3254.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质9 as an Impurity". Phytochemistry, 2016, 1897, (11), 6866-6896.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 9 Using HRMS and NMR". Chromatographia, 2014, 1894, (6), 6984-7005.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质9 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2023, 2333, (9), 6296-6323.